Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

Serum Acetylcholine Receptor Antibodies Before the Clinical Onset of Myasthenia Gravis.

Strijbos E, Verschuuren JJGM, Kuks JBM.

J Neuromuscul Dis. 2018;5(2):261-264. doi: 10.3233/JND-180313.

PMID:
29865092
2.

Clinical workplace learning: perceived learning value of individual and group feedback in a collectivistic culture.

Suhoyo Y, Schönrock-Adema J, Emilia O, Kuks JBM, Cohen-Schotanus J.

BMC Med Educ. 2018 Apr 19;18(1):79. doi: 10.1186/s12909-018-1188-0.

3.

Stability and relative validity of the Neuromuscular Disease Impact Profile (NMDIP).

Bos I, Kuks JBM, Almansa J, Kremer HPH, Wynia K.

BMC Neurol. 2017 May 11;17(1):87. doi: 10.1186/s12883-017-0866-6.

4.

Influence of feedback characteristics on perceived learning value of feedback in clerkships: does culture matter?

Suhoyo Y, Van Hell EA, Kerdijk W, Emilia O, Schönrock-Adema J, Kuks JB, Cohen-Schotanus J.

BMC Med Educ. 2017 Apr 5;17(1):69. doi: 10.1186/s12909-017-0904-5.

5.

The extremity function index (EFI), a disability severity measure for neuromuscular diseases: psychometric evaluation.

Bos I, Wynia K, Drost G, Almansa J, Kuks JBM.

Disabil Rehabil. 2018 Jun;40(13):1561-1568. doi: 10.1080/09638288.2017.1300690. Epub 2017 Mar 14.

PMID:
28291950
6.

An up-to-date overview of neurology training in Europe.

Zis P, Kuks JB.

Eur J Neurol. 2016 Oct;23(10):e66-74. doi: 10.1111/ene.13114. No abstract available.

PMID:
27629429
7.

The epidemiology of neuromuscular disorders: Age at onset and gender in the Netherlands.

Deenen JC, van Doorn PA, Faber CG, van der Kooi AJ, Kuks JB, Notermans NC, Visser LH, Horlings CG, Verschuuren JJ, Verbeek AL, van Engelen BG.

Neuromuscul Disord. 2016 Jul;26(7):447-52. doi: 10.1016/j.nmd.2016.04.011. Epub 2016 Apr 21.

PMID:
27212207
8.

Myasthenia gravis with muscle specific kinase antibodies mimicking amyotrophic lateral sclerosis.

Huijbers MG, Niks EH, Klooster R, de Visser M, Kuks JB, Veldink JH, Klarenbeek P, Van Damme P, de Baets MH, van der Maarel SM, van den Berg LH, Verschuuren JJ.

Neuromuscul Disord. 2016 Jun;26(6):350-3. doi: 10.1016/j.nmd.2016.04.004. Epub 2016 Apr 6.

PMID:
27133662
9.

Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity.

Huijbers MG, Vink AF, Niks EH, Westhuis RH, van Zwet EW, de Meel RH, Rojas-García R, Díaz-Manera J, Kuks JB, Klooster R, Straasheijm K, Evoli A, Illa I, van der Maarel SM, Verschuuren JJ.

J Neuroimmunol. 2016 Feb 15;291:82-8. doi: 10.1016/j.jneuroim.2015.12.016. Epub 2016 Jan 5.

PMID:
26857500
10.

Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis.

Obici L, Kuks JB, Buades J, Adams D, Suhr OB, Coelho T, Kyriakides T; European Network for TTR-FAP (ATTReuNET).

Curr Opin Neurol. 2016 Feb;29 Suppl 1:S27-35. doi: 10.1097/WCO.0000000000000290. Review.

11.

Development and testing psychometric properties of an ICF-based health measure: The Neuromuscular Disease Impact Profile.

Bos I, Kuks JB, Wynia K.

J Rehabil Med. 2015 May;47(5):445-53. doi: 10.2340/16501977-1938.

12.

Meeting international standards: a cultural approach in implementing the mini-CEX effectively in Indonesian clerkships.

Suhoyo Y, Schönrock-Adema J, Rahayu GR, Kuks JB, Cohen-Schotanus J.

Med Teach. 2014 Oct;36(10):894-902. doi: 10.3109/0142159X.2014.917160. Epub 2014 Sep 2.

PMID:
25180877
13.

Student distress in clinical workplace learning: differences in social comparison behaviours.

Janet Raat AN, Schönrock-Adema J, van Hell EA, Kuks JB, Cohen-Schotanus J.

Adv Health Sci Educ Theory Pract. 2015 Mar;20(1):101-11. doi: 10.1007/s10459-014-9513-9. Epub 2014 May 17.

PMID:
24838597
14.

Exploring cultural differences in feedback processes and perceived instructiveness during clerkships: replicating a Dutch study in Indonesia.

Suhoyo Y, van Hell EA, Prihatiningsih TS, Kuks JB, Cohen-Schotanus J.

Med Teach. 2014 Mar;36(3):223-9. doi: 10.3109/0142159X.2013.853117. Epub 2013 Dec 2.

PMID:
24289226
15.

Open-book tests: search behaviour, time used and test scores.

Westerkamp AC, Heijne-Penninga M, Kuks JB, Cohen-Schotanus J.

Med Teach. 2013 Apr;35(4):330-2. doi: 10.3109/0142159X.2013.759641. Epub 2013 Jan 18.

PMID:
23327562
16.

Peer influence on students' estimates of performance: social comparison in clinical rotations.

Raat AN, Kuks JB, van Hell EA, Cohen-Schotanus J.

Med Educ. 2013 Feb;47(2):190-7. doi: 10.1111/medu.12066.

PMID:
23323658
17.

Validation of the ICF core set for neuromuscular diseases.

Bos I, Stallinga HA, Middel B, Kuks JB, Wynia K.

Eur J Phys Rehabil Med. 2013 Apr;49(2):179-87. Epub 2012 Nov 21.

18.

Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study.

van der Beek NA, de Vries JM, Hagemans ML, Hop WC, Kroos MA, Wokke JH, de Visser M, van Engelen BG, Kuks JB, van der Kooi AJ, Notermans NC, Faber KG, Verschuuren JJ, Reuser AJ, van der Ploeg AT, van Doorn PA.

Orphanet J Rare Dis. 2012 Nov 12;7:88. doi: 10.1186/1750-1172-7-88.

19.

Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study.

de Vries JM, van der Beek NA, Hop WC, Karstens FP, Wokke JH, de Visser M, van Engelen BG, Kuks JB, van der Kooi AJ, Notermans NC, Faber CG, Verschuuren JJ, Kruijshaar ME, Reuser AJ, van Doorn PA, van der Ploeg AT.

Orphanet J Rare Dis. 2012 Sep 26;7:73. doi: 10.1186/1750-1172-7-73.

20.

Influence of PBL with open-book tests on knowledge retention measured with progress tests.

Heijne-Penninga M, Kuks JB, Hofman WH, Muijtjens AM, Cohen-Schotanus J.

Adv Health Sci Educ Theory Pract. 2013 Aug;18(3):485-95. doi: 10.1007/s10459-012-9386-8. Epub 2012 Jun 27.

Supplemental Content

Loading ...
Support Center